Latent gammaherpesvirus 68 infection induces distinct transcriptional changes in different organs

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 730-738

  Canny, Susan P ^a   Goel, Gautam ^b,c   Reese, Tiffany A ^a   Zhang, Xin ^a   Xavier, Ramnik ^b,c   Virgin, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CCL5 GENE; CXCL9 GENE; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS 68; GAMMAHERPESVIRUS INFECTION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HERPES VIRUS INFECTION; IFN GAMMA GENE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; TISSUE DISTRIBUTION; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HUMANS; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EID: 84890865176     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02708-13     Document Type: Article

References (27)

1. Virgin HW, Wherry EJ, Ahmed R. 2009. Redefining chronic viral infection. Cell 138:30-50. http://dx.doi.org/10.1016/j.cell.2009.06.036.
2. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447:326-329. http: //dx.doi.org/10.1038/nature05762.
3. White DW, Keppel CR, Schneider SE, Reese TA, Coder J, Payton JE, Ley TJ, Virgin HW, Fehniger TA. 2010. Latent herpesvirus infection arms NK cells. Blood 115:4377-4383. http://dx.doi.org/10.1182/blood -2009-09-245464.
4. Yager EJ, Szaba FM, Kummer LW, Lanzer KG, Burkum CE, Smiley ST, Blackman MA. 2009. Gamma-herpesvirus-induced protection against bacterial infection is transient. Viral Immunol. 22:67-71. http://dx.doi .org/10.1089/vim.2008.0086.
5. Haque A, Rachinel N, Quddus MR, Haque S, Kasper LH, Usherwood E. 2004. Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clin. Exp. Immunol. 138:396-404. http://dx.doi.org/10.1111/j.1365 -2249.2004.02652.x.
6. Nguyen Y, McGuffie BA, Anderson VE, Weinberg JB. 2008. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology 380:182-190. http://dx.doi.org/10.1016/j.virol.2008.07.031.
7. Casiraghi C, Shanina I, Cho S, Freeman ML, Blackman MA, Horwitz MS. 2012. Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis. PLoS Pathog. 8:e1002715. http://dx.doi.org/10.1371/journal.ppat.1002715.
8. Peacock JW, Elsawa SF, Petty CC, Hickey WF, Bost KL. 2003. Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. Eur. J. Immunol. 33:1849- 1858. http://dx.doi.org/10.1002/eji.200323148.
9. Nelson DA, Petty CC, Bost KL. 2009. Infection with murine gammaherpesvirus 68 exacerbates inflammatory bowel disease in IL-10-deficient mice. Inflamm. Res. 58:881-889. http://dx.doi.org/10.1007/s00011-009 -0059-x.
10. Fowler P, Marques S, Simas JP, Efstathiou S. 2003. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J. Gen. Virol. 84:3405-3416. http://dx.doi.org/10.1099/vir.0 .19594-0.
11. Moorman NJ, Willer DO, Speck SH. 2003. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J. Virol. 77:10295-10303. http://dx.doi.org/10 .1128/JVI.77.19.10295-10303.2003.
12. Tibbetts SA, Loh J, Van Berkel V, McClellan JS, Jacoby MA, Kapadia SB, Speck SH, Virgin HW, IV. 2003. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77:7696-7701. http://dx.doi.org/10.1128/JVI.77.13 .7696-7701.2003.
13. Silver AC, Arjona A, Walker WE, Fikrig E. 2012. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 36:251-261. http://dx.doi.org/10.1016/j.immuni.2011.12.017.
14. White DW, Beard RS, Barton ES. 2012. Immune modulation during latent herpesvirus infection. Immunol. Rev. 245:189-208. http://dx.doi .org/10.1111/j.1600-065X.2011.01074.x.
15. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102.
16. Gangappa S, van Dyk LF, Jewett TJ, Speck SH, Virgin HW. 2002. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195:931-940. http://dx.doi.org/10.1084/jem.20011825.
17. Steed AL, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, Rochford R,Virgin HW, IV. 2006. Gamma interferon blocks gammaherpesvirus reactivation from latency. J. Virol. 80:192-200. http://dx.doi.org/10.1128 /JVI.80.1.192-200.2006.
18. Tibbetts SA, van Dyk LF, Speck SH, Virgin HW. 2002. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J. Virol. 76:7125-7132. http://dx.doi.org/10.1128/JVI .76.14.7125-7132.2002.
19. Maloney NS, Thackray LB, Goel G, Hwang S, Duan E, Vachharajani P, Xavier R, Virgin HW. 2012. Essential cell-autonomous role for interferon (IFN) regulatory factor 1 in IFN-gamma-mediated inhibition of norovirus replication in macrophages. J. Virol. 86:12655-12664. http://dx.doi .org/10.1128/JVI.01564-12.
20. Saito F, Ito T, Connett JM, Schaller MA, Carson WF, IV, Hogaboam CM, Rochford R, Kunkel SL. 27 June 2013. MHV68 latency modulates the host immune response to influenza A virus. Inflammation. http://dx .doi.org/10.1007/s10753-013-9668-1.
21. Cho H, Shrestha B, Sen GC, Diamond MS. 2013. A role for Ifit2 in restricting West Nile virus infection in the brain. J. Virol. 87:8363-8371. http://dx.doi.org/10.1128/JVI.01097-13.
22. Daffis S, Samuel MA, Keller BC, Gale M, Jr, Diamond MS. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog. 3:e106. http://dx.doi.org/10.1371/journal.ppat.0030106.
23. Henig N, Avidan N, Mandel I, Staun-Ram E, Ginzburg E, Paperna T, Pinter RY, Miller A. 2013. Interferon-beta induces distinct gene expression response patterns in human monocytes versus T cells. PLoS One 8:e62366. http://dx.doi.org/10.1371/journal.pone.0062366.
24. Presti RM, Popkin DL, Connick M, Paetzold S, Virgin HW. 2001. Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages. J. Exp. Med. 193:483-496. http://dx.doi.org/10.1084/jem.193.4 .483.
25. Terenzi F, White C, Pal S, Williams BR, Sen GC. 2007. Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J. Virol. 81:8656-8665. http://dx.doi.org/10.1128/JVI.00322-07.
26. Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, Levin M, Relman DA. 2010. Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One 5:e9753. http://dx.doi .org/10.1371/journal.pone.0009753.
27. Lees JR, Golumbek PT, Sim J, Dorsey D, Russell JH. 2008. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205:2633-2642. http://dx.doi.org/10 .1084/jem.20080155.